Skip to Main Content

Author Details

Davide Bedognetti
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
2010
116
41
PMIDPaper TitleJournal TitlePublished Year
37202560An integrated tumor, immune and microbiome atlas of colon cancer.Nat Med2023
37291737V<sub>4</sub> C<sub>3</sub> MXene Immune Profiling and Modulation of T Cell-Dendritic Cell Function and Interaction.Small Methods2023
37448622Organizing training workshops on gene literature retrieval, profiling, and visualization for early career researchers.F1000Res2023
34796889Graphene oxide activates B cells with upregulation of granzyme B expression: evidence at the single-cell level for its immune-modulatory properties and anticancer activity.Nanoscale2022
35690832The immune landscape of solid pediatric tumors.J Exp Clin Cancer Res2022
36595917Analytic pipelines to assess the relationship between immune response and germline genetics in human tumors.STAR Protoc2022
36180904Immune-related 3-lncRNA signature with prognostic connotation in a multi-cancer setting.J Transl Med2022
36207284Immune Profiling and Multiplexed Label-Free Detection of 2D MXenes by Mass Cytometry and High-Dimensional Imaging.Adv Mater2022
36367935High-temporal resolution profiling reveals distinct immune trajectories following the first and second doses of COVID-19 mRNA vaccines.Sci Adv2022
36293565Correlation of Immunological and Histopathological Features with Gene Expression-Based Classifiers in Colon Cancer Patients.Int J Mol Sci2022
36215697Loss of ribonuclease DIS3 hampers genome integrity in myeloma by disrupting DNA:RNA hybrid metabolism.EMBO J2022
33926791miRNAs as novel immunoregulators in cancer.Semin Cell Dev Biol2022
35017155Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature.J Immunother Cancer2022
35150601Genetic predisposition to cancer across people of different ancestries in Qatar: a population-based, cohort study.Lancet Oncol2022
35303879Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments.Mol Cancer2022
35174610Transcriptomic profile investigations highlight a putative role for NUDT16 in sepsis.J Cell Mol Med2022
34789537Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer.Cancer Discov2022
33390169Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy.Mol Cancer2021
33602280Emerging dynamics pathways of response and resistance to PD-1 and CTLA-4 blockade: tackling uncertainty by confronting complexity.J Exp Clin Cancer Res2021
33624743BloodGen3Module: blood transcriptional module repertoire analysis and visualization using R.Bioinformatics2021
337539822D MXenes with antiviral and immunomodulatory properties: A pilot study against SARS-CoV-2.Nano Today2021
33637674Correction: Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy.Signal Transduct Target Ther2021
33614648Insights Into the Role of CircRNAs: Biogenesis, Characterization, Functional, and Clinical Impact in Human Malignancies.Front Cell Dev Biol2021
33558495Ancestry-associated transcriptomic profiles of breast cancer in patients of African, Arab, and European ancestry.NPJ Breast Cancer2021
34956864Bulk and Single-Cell Profiling of Breast Tumors Identifies TREM-1 as a Dominant Immune Suppressive Marker Associated With Poor Outcomes.Front Oncol2021
34303699Myeloid Cells Are Enriched in Tonsillar Crypts, Providing Insight into the Viral Tropism of Human Papillomavirus.Am J Pathol2021
34185403Integrated transcriptional-phenotypic analysis captures systemic immunomodulation following antiangiogenic therapy in renal cell carcinoma patients.Clin Transl Med2021
33979427Network-based identification of key master regulators associated with an immune-silent cancer phenotype.Brief Bioinform2021
34282143Development of a fixed module repertoire for the analysis and interpretation of blood transcriptome data.Nat Commun2021
33436555Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy.Signal Transduct Target Ther2021
33408218Prospective validation study of prognostic biomarkers to predict adverse outcomes in patients with COVID-19: a study protocol.BMJ Open2021
33139798A balance score between immune stimulatory and suppressive microenvironments identifies mediators of tumour immunity and predicts pan-cancer survival.Br J Cancer2021
33277603Correction: A balance score between immune stimulatory and suppressive microenvironments identifies mediators of tumour immunity and predicts pan-cancer survival.Br J Cancer2021
31502155Functional Genome Profiling to Understand Cancer Immune Responsiveness.Methods Mol Biol2020
35121932Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets.Nat Cancer2020
33377660Definition of erythroid cell-positive blood transcriptome phenotypes associated with severe respiratory syncytial virus infection.Clin Transl Med2020
33142138Expression of NK cell receptor ligands in primary colorectal cancer tissue in relation to the phenotype of circulating NK- and NKT cells, and clinical outcome.Mol Immunol2020
33329570A Neutrophil-Driven Inflammatory Signature Characterizes the Blood Transcriptome Fingerprint of Psoriasis.Front Immunol2020
33155039A map of tumor-host interactions in glioma at single-cell resolution.Gigascience2020
32711099Sterol synthesis pathway inhibition as a target for cancer treatment.Cancer Lett2020
32682335Annexin A3 in sepsis: novel perspectives from an exploration of public transcriptome data.Immunology2020
32630545HLA-G: A New Immune Checkpoint in Cancer?Int J Mol Sci2020
32736569A modular framework for the development of targeted Covid-19 blood transcript profiling panels.J Transl Med2020
32931741A Multi-layer Molecular Fresco of the Immune Diversity across Hematologic Malignancies.Cancer Cell2020
32393282Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated.J Transl Med2020
32338440Toward High-Dimensional Single-Cell Analysis of Graphene Oxide Biological Impact: Tracking on Immune Cells by Single-Cell Mass Cytometry.Small2020
32215869The Biology of Immune-Active Cancers and Their Regulatory Mechanisms.Cancer Treat Res2020
32519842Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic.ACS Nano2020
32373222Graphene and other 2D materials: a multidisciplinary analysis to uncover the hidden potential as cancer theranostics.Theranostics2020
30953523Monoallelic expression in melanoma.J Transl Med2019
  • 1 - 50 of 116

Recommended Authors

University of California San Francisco
Career Start Year 2018
Number of shared co-authors 3
International Research Center, A.C.Camargo Cancer Center
Career Start Year 2016
Number of shared co-authors 0
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 2014
Number of shared co-authors 1
Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 0
Massachusetts Institute of Technology
Career Start Year 2013
Number of shared co-authors 1
Mayo Clinic
Career Start Year 2010
Number of shared co-authors 2
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 0
the University of Texas MD Anderson Cancer Center
Career Start Year 2009
Number of shared co-authors 11
Georgia Cancer Center, Medical College of Georgia
Career Start Year 2008
Number of shared co-authors 3
St Vincent's Hospital Melbourne
Career Start Year 2006
Number of shared co-authors 6
The University of Texas M. D. Anderson
Career Start Year 2006
Number of shared co-authors 15
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 12
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 2
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 0
University of Colorado Anschutz Medical Campus
Career Start Year 2002
Number of shared co-authors 0
Bloomberg-Kimmel Immunotherapy Institute, Johns Hopkins University School of Medicine
Career Start Year 2001
Number of shared co-authors 12
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 2
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 1
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 4
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 2
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 10
Cleveland Clinic.
Career Start Year 1994
Number of shared co-authors 22
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1994
Number of shared co-authors 3
Hunter Medical Research Institute, University of Newcastle
Career Start Year 1993
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1992
Number of shared co-authors 1
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 5
Convergence Institute, Johns Hopkins University
Career Start Year 1985
Number of shared co-authors 6
Australia Olivia Newton-John Cancer Research Institute, La Trobe University
Career Start Year 1985
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 1978
Number of shared co-authors 1
University of California Los Angeles (university of california los angeles)
Career Start Year 1972
Number of shared co-authors 8

Collaborators

University of Genoa and Ospedale Policlinico San Martino
Co-authored papers 15
Co-authored papers 13
Co-authored papers 13
Co-authored papers 8
Center for Cellular Engineering, NIH Clinical Center, National Institutes of Health
Co-authored papers 7
Institute for Human Genetics, University of California San Francisco (UCSF)
Co-authored papers 6
Qatar University
Co-authored papers 5
Institute for Systems Biology
Co-authored papers 4
University of Washington Medicine Cancer Vaccine Institute, University of Washington
Co-authored papers 4
Co-authored papers 4
Wake Forest University School of Medicine
Co-authored papers 4
University of Washington School of Medicine, Seattle Benaroya Research Institute
Co-authored papers 4
Co-authored papers 4
University of Colorado School of Medicine
Co-authored papers 3
Ontario Institute for Cancer Research
Co-authored papers 3
Weill Cornell Medical College
Co-authored papers 3
National Cancer Institute
Co-authored papers 3
National Cancer Institute, National Institutes of Health (NIH)
Co-authored papers 2
Center for Human Immunology
Co-authored papers 2
University of Virginia
Co-authored papers 2
Center for Cellular Engineering, National Institutes of Health Clinical Center
Co-authored papers 2
Co-authored papers 2
St. Jude Children's Research Hospital
Co-authored papers 2
Weill Cornell Medical College
Co-authored papers 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
Co-authored papers 2
University of Rome 'Tor Vergata'
Co-authored papers 2
Benaroya Research Institute
Co-authored papers 1